Meitheal Pharmaceuticals has Micafungin for Injection, Now Available

Share Facebook icon Twitter icon Linkedin icon

Meitheal Pharmaceuticals (Meitheal) is pleased to announce that we have launched Micafungin for Injection in 50 mg per vial in a single-dose vial and 100 mg per vial in a single-dose vial.

Meitheal will offer Micafungin for Injection in packs of 10 vials for both presentations.


Micafungin for Injection is indicated in adult and pediatric patients for the treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses in adult and pediatric patients 4 months of age and older. For full prescribing information, and safety information, including boxed warning, please click on the following link.


Learn more about Micafungin for Injection

This Website Uses Cookies

This website uses cookies to help us give you the best experience when you visit. By clicking “Accept Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can read more about our use of cookies in our Privacy Policy.

Accept cookies Reject cookies